• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE PROX EVEROLIMUS ELUTING RX CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE PROX EVEROLIMUS ELUTING RX CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1076400-12
Device Problems Difficult to Remove (1528); Improper or Incorrect Procedure or Method (2017); Difficult or Delayed Activation (2577)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/19/2019
Event Type  malfunction  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.(b)(4).The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.The xience prox device is currently not commercially available in the us; however, it is similar to a device sold in the us.
 
Event Description
It was reported that the procedure was to treat a moderately tortuous and moderately calcified mid ramus intermedius artery.An unspecified guide wire was advanced to the lesion, and pre-dilatation was performed with an unspecified balloon catheter.A 4.0 x 12 mm xience prox stent delivery system (sds) was then used.The balloon was inflated; however, there was difficulty in deploying the stent at first.The balloon was then inflated five times at 23 atmospheres and the stent was implanted; it was well apposed to the vessel.However, the stent delivery balloon could not be removed from the stent during removal.Therefore, the balloon was inflated again and then fully deflated.The sds was then able to be removed from the stent.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
Internal file number - (b)(4).Evaluation summary: the device was returned for analysis.The reported difficulty to deploy could not be confirmed as the stent was not returned for analysis.The reported difficulty to remove the device was unable to be replicated in a testing environment as it was based on operational circumstances.It should be noted that the xience sierra everolimus eluting coronary stent system instruction for use, states: note: do not exceed the labeled rated burst pressure (rbp).In this case, it does not appear the ifu deviation contributed to the reported difficulties.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation was unable to determine a conclusive cause for the reported difficulty to deploy.The reported difficulty to remove appears to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE PROX EVEROLIMUS ELUTING RX CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8497855
MDR Text Key141450693
Report Number2024168-2019-02758
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup
Report Date 05/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/25/2020
Device Catalogue Number1076400-12
Device Lot Number7091541
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/12/2019
Initial Date Manufacturer Received 03/18/2019
Initial Date FDA Received04/09/2019
Supplement Dates Manufacturer Received04/29/2019
Supplement Dates FDA Received05/20/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-